This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations in Cancer Treatment by Hussein A Tawbi
Introduction
Hussein A Tawbi is an accomplished inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on enhancing the effectiveness of chemotherapy by utilizing genetic insights.
Latest Patents
Hussein A Tawbi holds a patent for a method titled "PARP genomic variants conferring resistance and sensitization to chemotherapy under inhibition." This patent outlines a method for selecting cancer patients as candidates for treatment with a PARP1 inhibitor, or a combination of a PARP1 inhibitor and a chemotherapeutic agent. The method involves detecting mutations in a non-coding region of the PARP1 gene, which can indicate the suitability of treatment with the PARP1 inhibitor, such as verliparib (ABT-888).
Career Highlights
Hussein A Tawbi is affiliated with the University of Pittsburgh, where he conducts his research and develops innovative solutions for cancer treatment. His work has the potential to significantly improve patient outcomes by personalizing treatment strategies based on genetic profiles.
Collaborations
Hussein collaborates with notable colleagues, including Petr Pancoska and Irina Abecassis, to advance research in the field of oncology. Their combined expertise contributes to the development of effective cancer therapies.
Conclusion
Hussein A Tawbi's innovative approach to cancer treatment through his patented methods exemplifies the importance of integrating genetic research with therapeutic strategies. His contributions are paving the way for more effective and personalized cancer care.